Lyell Immunopharma (LYEL)'s 30-day implied volatility (IV30) was 77.5% at the close on November 2, 2026, down from 86.6% the day before, against a 52-week range of 56.1% to 102.5%. Its 20-day historical volatility was 105.2%.
Data as of November 2, 2026.